[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lee et al., 2012 - Google Patents

A new splice variant of the glutamate–aspartate transporter: Cloning and immunolocalization of GLAST1c in rat, pig and human brains

Lee et al., 2012

Document ID
5408475995894501892
Author
Lee A
Anderson A
Beasley S
Barnett N
Poronnik P
Pow D
Publication year
Publication venue
Journal of chemical neuroanatomy

External Links

Snippet

GLAST (EAAT1) is an abundant glial glutamate transporter in the mammalian brain. It plays important roles in terminating excitatory transmission in grey matter, as well as pathophysiological roles, including protecting white matter from excitotoxic injury. In normal …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Jablonka et al. Axonal defects in mouse models of motoneuron disease
Zaltieri et al. α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons
Lee et al. A new splice variant of the glutamate–aspartate transporter: Cloning and immunolocalization of GLAST1c in rat, pig and human brains
Latour et al. Expression of voltage‐gated Ca2+ channel subtypes in cultured astrocytes
Tessler et al. Expression of the glutamate transporters in human temporal lobe epilepsy
Loebrich et al. Activated radixin is essential for GABAA receptor α5 subunit anchoring at the actin cytoskeleton
Tomioka et al. Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures
Bhattacharjee et al. Localization of the Slack potassium channel in the rat central nervous system
Dupraz et al. The TC10–Exo70 complex is essential for membrane expansion and axonal specification in developing neurons
Hsiao et al. Cyfip1 regulates presynaptic activity during development
Pedrola et al. Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot‐Marie‐Tooth type 4A disease
Sailer et al. Immunolocalization of BK channels in hippocampal pyramidal neurons
Azmitia et al. Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain
Wang et al. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain
Miesfeld et al. The dynamics of native Atoh7 protein expression during mouse retinal histogenesis, revealed with a new antibody
Fischer et al. Transient expression of LIM‐domain transcription factors is coincident with delayed maturation of photoreceptors in the chicken retina
Hurt et al. REEP1 and REEP2 proteins are preferentially expressed in neuronal and neuronal-like exocytotic tissues
Zhao et al. Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking
Hashiguchi et al. Ataxic phenotype with altered CaV3. 1 channel property in a mouse model for spinocerebellar ataxia 42
Vijay et al. Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C
Weis et al. Denervation induces a rapid nuclear accumulation of MRF4 in mature myofibers
Goodyear et al. Identification of the hair cell soma-1 antigen, HCS-1, as otoferlin
Suwa et al. Distribution of serotonin 4 (a) receptors in the juvenile rat brain and spinal cord
Nakaya et al. Impaired AMPA receptor trafficking by a double knockout of zebrafish olfactomedin1a/b
US12116611B2 (en) Method of treating intellectual disability, autism and epilepsy associated with an IQSEC2 mutation and for identifying medicaments for treating the same